Gunjan Verma - India

The CDSCO is reminding manufacturers of Non-Notified Class C and D medical device products to submit an MD-14 application for an Import License to have approval by the October 1 deadline.

Gunjan Verma
Managing Partner
Asia Actual India

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Sign Up For Our Newsletter to Stay Informed

Sign Up

India CDSCO Alerts Manufacturers to Non-Notified Class C and D Deadline

Published on: April 21st, 2023

On October 1st 2023, the India CDSCO will enforce full license requirements for Class C and D non-notified medical devices as the final step of transitioning all medical devices under the new rules. The CDSCO is currently alerting manufacturers/importers to this deadline as the majority of Class C and D medical device manufacturers will be affected, since they were previously exempted from the regulatory requirements.  

Manufacturers must apply for a grant of manufacturing or import license with all the requisite documents and fees outlined in the MDR, 2017 by the October deadline, or face potential market interruption. The import license application process takes at least 6 months so it is imperative to begin the application submission process as soon as possible to meet the October 1st 2023 deadline. 

An application for a grant of manufacturing/import license will be processed proactively by the CDSCO so it can be issued within the stipulated timeframe (prior to October 1st, 2023) in order to avoid any disruption of the supply of medical devices in India. 

If you have questions about the application process for an Import License for Class C and D medical devices from the CDSCO, please contact us here. You can also read more about import license requirements from the CDSCO on our website 

CDSCO Import License Applications Can Take up to 6 Months

All potential applicants for import of Class C and D non-notified medical devices need to begin application submission as soon as possible in order to complete the submission on time and avoid potential disruption during the importing process.  

This is to avoid similar problems/uncertainty many manufacturers/importers experienced when the Class A and B medical device import license requirements were put in place by the CDSCO for October 1st, 2022. Many manufacturers worried about the status of their import licenses after sending in late applications, which resulted in an extended grace period from the CDSCO for already submitted import license applications.  

More information on the CDSCO’s Class A and B medical device import license requirements can be found on our website. Information on the timeline of implementation for Import Licenses by the CDSCO can be found in the G.S.R. 102 (E) notification from 2022. 

Grow With Us

Please contact us if you have questions about submitting an application for a grant of manufacturing/import license with the CDSCO. Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests.   

Asia Actual is a regulatory consulting company focused on helping manufacturers grow sales in challenging Asia markets through independent license holding, direct fulfilment, and a variety of sales channel support services.     

Blog Posts

Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Thai FDA Documentation Exemptions for Concise and Full Regulatory Pathways

Thai FDA Regulatory Documentation Exemptions

March 12, 2024: the Thai FDA released draft guidance updating the list of required documentation for Full and Concise Evaluation. For manufacturers registering a medical device in Thailand, certain documents are no longer required.
Hong Kong MDD adds Singapore HSA to Reference Country List

Hong Kong MDD Adds Singapore as Reference Country

Starting April 2nd, 2024, the Hong Kong Medical Device Division (MDD) accepts, on a regular basis, the marketing approvals obtained from the the Health Sciences Authority (HSA) of Singapore as a support of compliance of medical device to the "Essential Principles of Safety and Performance of Medical Devices" (Technical Reference: TR-004) under MDACS.